Anavex Life Sciences Corp. (NASDAQ: AVXL) is a leader in utilizing precision genetic medicine to treat severe neurological diseases with no available therapy, such as Rett syndrome, as well as age-related neurodegenerative diseases such as Alzheimer’s Disease and Parkinson’s Disease.
The pharmaceutical sector has seen some ups and downs in the past several years. Especially with the rise of vaccinations and a bigger focus on health, any medically-related stock is sure to be affected.
This is definitely true of Anavex Life Sciences Corp (NASDAQ: AVXL) as they continue to conduct trials for their drugs ...
Read The Full Article On StreetSignals.com
Get the latest stock market news on StreetSignals . Follow public companies and get free stock research reports and stock market analysis data and stock tips.
All content provided by StreetSignals is subject to our Terms Of Use and Disclaimer .
For further details see:
Why Did This Pharma Stock Shoot Up 300% in 1 Year?